Tirzepatide
Dual GLP-1 and GIP receptor agonist delivering superior weight loss and metabolic results compared to single-agonist alternatives. Targets two key hunger and insulin pathways simultaneously for accelerated fat loss, improved blood sugar control, and enhanced energy regulation.